Clindamycin shortage — CA supply status & alternatives

Clindamycin

ATC D10AF01

🇦🇺 AUST R 406130 · Nova Pharmaceuticals Australasia Pty Ltd

In supply · Australia

ApoDalacin CClindamycin HClCleocin HydrochlorideClindamycin Phosphate+3 more

In supply · 🇦🇺 Australia · short in🇨🇦 CA🇧🇪 BE🌐 MY

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$4.00DPMQ A$22.84details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

Product attributes reference data we hold

Active ingredient (INN)	Clindamycin
Brand names	Apo, Dalacin C, Clindamycin HCl, Cleocin Hydrochloride, Clindamycin Phosphate, DALACIN C clindamycin +2 more
ATC level 5	D10AF01
ATC level 4	D10AF
Therapeutic category	Auto-created by Federal Agency for Medicines and Health Products — PharmaStatus scraper
Controlled substance	No
Marketing-authorisation holders	Nova Pharmaceuticals Australasia Pty Ltd, Pfizer Limited, HAMELN PHARMA LTD, Generics (UK) Limited +8 more
Registrations on file	22
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

1 API manufacturer

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Very high concentration risk

Chongqing Carelife Pharmaceutical CO LTD

Manufacturing countries: China · Source: FDA List of Drug Master Files

Recalls official enforcement reports

🇺🇸

Clindamycin

CMC Enterprise Pharmacy · Apr 2019

Class IIdetails ↗

🇺🇸

Clindamycin

Prescript Pharmaceuticals, Inc. · Apr 2018

Class IIdetails ↗

🇺🇸

Clindamycin

Prescript Pharmaceuticals, Inc. · Apr 2018

Class IIdetails ↗

🇺🇸

Clindamycin

Synergy Rx · Feb 2017

Class IIdetails ↗

🇺🇸

Clindamycin

Baptist Health Medical Towers Pharmacy and Infusion Services · Apr 2016

Class IIdetails ↗

🇺🇸

Clindamycin

Sentara Enterprises · Sept 2015

Class IIdetails ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders22 registrations · 12 MA holders

Product	Strength	Form	Market	MA holder	Status
NOVADAC ONCE DAILY GEL clindamycin 1% w/w / benzoyl peroxide 5% w/w topical gel tube	1%	—	🇦🇺 AU	Nova Pharmaceuticals Australasia Pty Ltd	Active
CLINDAMYCIN 150MG CAPSULES	150MG	capsule	🇬🇧 GB	Pfizer Limited	Active
CLINDAMYCIN 75MG CAPSULES	75MG	capsule	🇬🇧 GB	Pfizer Limited	Active
CLINDAMYCIN 150 MG/ML SOLUTION FOR INJECTION	150 MG	injection	🇬🇧 GB	Pfizer Limited	Active
Clindamycin 2% Cream	2%	cream	🇬🇧 GB	Pfizer Limited	Active
CLINDAMYCIN 10 MG/ML TOPICAL LOTION	10 MG	clindamycin	🇬🇧 GB	Pfizer Limited	Active
CLINDAMYCIN 150 MG/ML SOLUTION FOR INJECTION OR INFUSION	150 MG	injection	🇬🇧 GB	HAMELN PHARMA LTD	Active
CLINDAMYCIN 150 MG HARD CAPSULES	150 MG	capsule	🇬🇧 GB	Generics (UK) Limited	Active
CLINDAMYCIN 300 MG HARD CAPSULES	300 MG	capsule	🇬🇧 GB	Generics (UK) Limited	Active
CLINDAMYCIN 150MG/ML, SOLUTION FOR INJECTION	150MG	injection	🇬🇧 GB	ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI SPA	Active
CLINDAMYCIN 150MG HARD CAPSULES	150MG	capsule	🇬🇧 GB	CHANELLE MEDICAL UNLIMITED COMPANY	Active
Clindamycin Hydrochloride	150MG	capsule	🇬🇧 GB	STRANDHAVEN LIMITED	Active
CLINDAMYCIN 300MG CAPSULES, HARD	300MG	capsule	🇬🇧 GB	STRANDHAVEN LIMITED	Active
CLINDAMYCIN 150MG/ML SOLUTION FOR INJECTION OR INFUSION	150MG	injection	🇬🇧 GB	FOCUS PHARMACEUTICALS LIMITED	Active
CLINDAMYCIN 150MG CAPSULES, HARD	150MG	capsule	🇬🇧 GB	MORNINGSIDE HEALTHCARE LIMITED	Active

+7 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.